Literature DB >> 14559436

L-[1-13C] phenylalanine breath test reflects histological changes in the liver.

Yukimoto Ishii1, Shigeru Suzuki, Tomohisa Kohno, Masaru Aoki, Tadashi Kohno, Asuka Ito, Tadatoshi Takayama, Satoshi Asai.   

Abstract

OBJECTIVE: Compared with healthy individuals, patients with chronic liver disease reportedly have lower L-[1-13C] phenylalanine breath test (PBT) values. However, there is no report detailing the relationship between the results of PBT and pathological data in liver disease patients. This study was designed to investigate the degree of histological changes in the liver that induce PBT changes and the time of measurement that reflects the histological change.
MATERIALS AND METHODS: PBT was performed in 47 patients (10 with a normal liver, and 37 with chronic hepatitis C). After administering 10 mg/kg L-[1-13C] phenylalanine, 300 mL of expired air was collected over 90 min at 15-min intervals. The rate of hepatic phenylalanine oxidation (%13C dose h(-1)) at each time point was calculated from the amount of 13CO(2) in the exhaled air, assuming a CO(2) production rate of 300 mmol m(-2) body surface area per hour. Subsequently, we examined the relationship between the results of PBT and METAVIR pathological scoring.
RESULTS: The highest correlation coefficients between the fibrosis score and %13C dose h(-1) and between the fibrosis score and %13C cumulative excretion were obtained at 45 min (r = -0.779, R(2) = 0.607; P < 0.0001) and 75 min (r = -0.768, R(2) = 0.590; P < 0.0001), respectively.
CONCLUSION: PBT is a useful adjunct for detecting histological changes in the liver. The %13C dose h(-1) value at 45 min and the %13C cumulative excretion value at 75 min of PBT are useful for detecting hepatic histological change.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559436     DOI: 10.1016/s0022-4804(03)00278-6

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

Review 1.  Clinical utility of 13C-liver-function breath tests for assessment of hepatic function.

Authors:  P Afolabi; M Wright; S A Wootton; A A Jackson
Journal:  Dig Dis Sci       Date:  2012-08-17       Impact factor: 3.199

2.  Clinical research on liver reserve function by 13C-phenylalanine breath test in aged patients with chronic liver diseases.

Authors:  Gan-sheng Zhang; Zhi-jun Bao; Jian Zou; Shu-ming Yin; Yi-qin Huang; Hai Huang; De-kai Qiu
Journal:  BMC Geriatr       Date:  2010-05-12       Impact factor: 3.921

3.  Prognostic value of (13)C-phenylalanine breath test on predicting survival in patients with chronic liver failure.

Authors:  I Gallardo-Wong; S Morán; G Rodríguez-Leal; B Castañeda-Romero; R Mera; J Poo; M Uribe; M Dehesa
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

4.  Serum phenylalanine concentration as a marker of liver function in obese patients before and after bariatric surgery.

Authors:  Julian Swierczynski; Tomasz Sledzinski; Ewa Slominska; Ryszard Smolenski; Zbigniew Sledzinski
Journal:  Obes Surg       Date:  2008-04-23       Impact factor: 4.129

Review 5.  Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis.

Authors:  Julia J Witjes; Loek P Smits; Ceyda T Pekmez; Andrei Prodan; Abraham S Meijnikman; Marian A Troelstra; Kristien E C Bouter; Hilde Herrema; Evgeni Levin; Adriaan G Holleboom; Maaike Winkelmeijer; Ulrich H Beuers; Krijn van Lienden; Judith Aron-Wisnewky; Ville Mannisto; Jacques J Bergman; Jurgen H Runge; Aart J Nederveen; Lars O Dragsted; Prokopis Konstanti; Erwin G Zoetendal; Willem de Vos; Joanne Verheij; Albert K Groen; Max Nieuwdorp
Journal:  Hepatol Commun       Date:  2020-10-07

6.  A preliminary study of (13)c-phenylalanine and (13)c-dipeptide breath tests in horses.

Authors:  Naoki Sasaki; Nao Tsuzuki; Michiaki Yamada; Takuto Minami; Haruo Yamada
Journal:  J Equine Sci       Date:  2009-04-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.